The company had reported a net profit of Rs 148.68 crore for the October-December period a year ago.
Total income from operations of the company during the period under review were down 12.41 per cent to Rs 960.17 crore as against Rs 1,096.28 crore in the corresponding period last fiscal, GSK said in a BSE filing.
In a separate filing, said tenure of Subodh Bhargava as a non-executive chairman has been extended for a period of one year with effect from March 31, 2017.